Document is current
Any future updates will be listed below
-
Authors
Lei, Yuqing
Chen, Jiajie
Wu, Qiong
Zhou, Ting https://orcid.org/0000-0003-3392-2979
Zhang, Bingyu
Becich, Michael J. https://orcid.org/0000-0001-5998-8074
Bisyuk, Yuriy https://orcid.org/0000-0003-2380-4776
Blecker, Saul
Chrischilles, Elizabeth A.
Christakis, Dimitri A.
Cowell, Lindsay G.
Cummins, Mollie R. https://orcid.org/0000-0001-7078-8479
Fernandez, Soledad A. https://orcid.org/0009-0007-7848-9781
Fort, Daniel
Gonzalez, Sandy L.
Herring, Sharon J.
Horne, Benjamin D. https://orcid.org/0000-0002-2656-0263
Horowitz, Carol
Liu, Mei https://orcid.org/0000-0002-8036-2110
Kim, Susan
Mirhaji, Parsa
Mosa, Abu Saleh Mohammad https://orcid.org/0000-0002-8956-1466
Muszynski, Jennifer A.
Paules, Catharine I.
Sato, Alice I. https://orcid.org/0000-0001-9827-201X
Schwenk, Hayden T.
Sengupta, Soumitra
Suresh, Srinivasan
Taylor, Bradley W. https://orcid.org/0000-0002-6414-4172
Williams, David A. https://orcid.org/0000-0002-5052-4895
He, Yongqun https://orcid.org/0000-0001-9189-9661
Morris, Jeffrey S. https://orcid.org/0000-0002-8520-6088
Jhaveri, Ravi
Forrest, Christopher B. https://orcid.org/0000-0003-1252-068X
Chen, Yong https://orcid.org/0000-0003-0835-0788
,
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (OT2HL161847-01)
Patient-Centered Outcomes Research Institute (RI-CHOP-01-PS10)
- License Information
-
More Information
Article History
Received: 21 June 2025
Accepted: 31 March 2026
First Online: 17 April 2026
Competing interests
: Dr. Horne is a member of the advisory boards of Opsis Health and Lab Me Analytics, a consultant to Pfizer regarding risk scores (funds paid to Intermountain), and an inventor of risk scores licensed by Intermountain to Alluceo and CareCentra. Dr. Horne is site PI of a COVID-19 grant from the Task Force for Global Health, site PI of grants from the Patient-Centered Outcomes Research Institute, a member of the advisory board of Opsis Health, and previously consulted for Pfizer regarding risk scores (funds paid to Intermountain). Dr Jhaveri reported receiving personal fees from the AstraZeneca scientific advisory board, Seqirus scientific advisory board, Sanofi scientific advisory board, and Gilead scientific advisory board; grants from GSK; and an editorial stipend from the Pediatric Infectious Diseases Society for serving as editor-in-chief of the Journal of the Pediatric Infectious Diseases Society outside the submitted work. No other disclosures were reported.
